These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4381259)

  • 1. Adrenergic mechanism of the drugs. Systemic arterial pressure changes caused by intravenous injection of reserpine following the administration of pheniprazine and pyrogallol in anesthetized dogs.
    Takasak K
    Kurume Med J; 1966; 13(3):99-111. PubMed ID: 4381259
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of the pressor response to sympathomimetic amines by acutely administered reserpine in dogs.
    Takasaki K
    Kurume Med J; 1971; 18(2):89-102. PubMed ID: 4396622
    [No Abstract]   [Full Text] [Related]  

  • 3. On the mechanism of reversal of reserpine action by pargyline hydrochloride.
    Chopra YM; Dandiya PC
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):47-56. PubMed ID: 5350784
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the intraventricular administration of some hypotensive drugs on the arterial blood pressure and respiratory movements.
    Cuparencu B; Ticşa I; Csutak V; Safta L; Mocan R
    Acta Biol Med Ger; 1969; 23(6):799-812. PubMed ID: 5375482
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.
    WEIL-MALHERBE H; POSNER HS; BOWLES GR
    J Pharmacol Exp Ther; 1961 Jun; 132():278-86. PubMed ID: 13783846
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes of arterial blood pressure and respiration elicited by ventriculocerebral perfusion of some veratrum ester-alkaloids.
    Cuparencu B; Ticşa I; Csutak V; Safta L; Mocan R
    Acta Biol Med Ger; 1967; 19(3):435-46. PubMed ID: 5591161
    [No Abstract]   [Full Text] [Related]  

  • 7. [Identification of the hypertensive principle of colostrum as a nucleotide].
    Werle E; Schmal A; Zach HP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 259(1):45-55. PubMed ID: 4233262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of natrium gallate and some other polyphenols on systemic arterial pressure and tonus of vessels of the skeletal muscles in cats].
    Baraboĭ VA; Stoian OP
    Fiziol Zh; 1968; 14(6):782-90. PubMed ID: 5759868
    [No Abstract]   [Full Text] [Related]  

  • 9. Tachyphylaxis of indirectly acting sympathomimetic amines. I. Difference of pressor effect produced by repeated administration of ephedrine, methamphetamine and pheniprazine in dogs.
    Takasaki K; Kitagawa H; Ishibashi S
    Kurume Med J; 1972; 19(1):1-10. PubMed ID: 4401246
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of carotid arterial and intravenous propofol administration for electrocerebral silence on circulation and respiration in dogs].
    Gai CL; Chen WM; Zheng XC; Ran DC; Ai CL; Sun ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1799-802. PubMed ID: 17259124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tooth pulp pressure: local and systemic influences of epinephrine and acetylcholine.
    Cauvin CA; Kirkendol PL
    Pharmacol Ther Dent; 1980; 5(1-2):17-24. PubMed ID: 6932047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of catecholamines by a new diphenylalkanolamine. I. Studies in vivo and general pharmacology.
    Kasuya Y; Watanabe M
    Arzneimittelforschung; 1965 Nov; 15(11):1279-84. PubMed ID: 4382189
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of pyrogallol and 4-tropoloneacetamide.
    Glavas E; Trajkov T; Nikodijeviç B
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):134-7. PubMed ID: 4383321
    [No Abstract]   [Full Text] [Related]  

  • 14. Some cardiovascular actions of iproniazid and pyrogallol.
    Sogani RK; Sharma VN
    Indian J Physiol Pharmacol; 1965 Jul; 9(3):103-10. PubMed ID: 5887639
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of antiadrenergic measures on the blood catecholamine level in protracted intracranial hypertension.
    Eichbaum FW; Spanoudis S; Aguiar A; Ramos AO
    Z Kreislaufforsch; 1969 Apr; 58(4):430-9. PubMed ID: 4389753
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of the pressor effect of amodiaquin and chloroquine in methylamphetamine-pretreated anesthetized dogs.
    Jindal MN; Pandya KH; Kelkar VV
    J Pharmacol Exp Ther; 1968 May; 161(1):70-7. PubMed ID: 4384875
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in blood level of catecholamines during arterial blood pressure rise induced with sciatic nerve stimulation.
    Całkosiński I; Switała M
    Acta Physiol Pol; 1984; 35(1):47-51. PubMed ID: 6534081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the growth of Tetrahymena by compounds which affect the adrenergic mechanism.
    Iwata H; Kariya K; Fujimoto S
    Jpn J Pharmacol; 1967 Jun; 17(2):328-9. PubMed ID: 5299993
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of the vasodilator response to pheniprazine.
    Mohammed S; Hardman HF; Yard AC
    J Pharmacol Exp Ther; 1967 May; 156(2):221-6. PubMed ID: 4381700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.